<p>EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC</p>

Jiao Meng(Shanghai Medical College of Fudan University), Wei Liu(The Fourth People's Hospital)
OncoTargets and Therapy
July 1, 2019
Cited by 64


Related Papers